Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine

被引：0

作者：

Tepper, Stewart ^{[1
]}

Ashina, Messoud ^{[2
]}

Reuter, Uwe ^{[3
]}

Brandes, Jan L. ^{[4
,5
]}

Dolezil, David ^{[6
]}

Silberstein, Stephen ^{[7
]}

Winner, Paul ^{[8
]}

Zhang, Feng ^{[9
]}

Cheng, Sunfa ^{[10
]}

Mikol, Daniel ^{[10
]}

机构：

[1] Geisel Sch Med Dartmouth, Hanover, NH USA

[2] Univ Copenhagen, Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark

[3] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[4] Nashville Neurosci Grp, Nashville, TN USA

[5] Vanderbilt Univ, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA

[6] DADO MED Sro, Prague Headache Ctr, Prague, Czech Republic

[7] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[8] Nova Southeastern Univ, Premiere Res Inst, W Palm Beach, FL USA

[9] Amgen Inc, Global Bio Stat Sci, Thousand Oaks, CA 91320 USA

[10] Amgen Inc, Global Dev, Thousand Oaks, CA 91320 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P24

引用

页数：2